BlackRock, Inc. (BLK) 13D/13G Filings for Lyell Immunopharma, Inc. (LYEL)

BlackRock, Inc. 13D and 13G filings for Lyell Immunopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-05
1:23 pm
Sale		 2024-12-31 13G Lyell Immunopharma, Inc.
LYEL		 BlackRock Inc.
BLK		 13,265,869
4.500%		 -1,036,351decrease
(-7.25%)		 Filing
2024-01-29
5:25 pm
Purchase		 2023-12-31 13G Lyell Immunopharma, Inc.
LYEL		 BlackRock Inc.
BLK		 14,302,220
5.700%		 14,302,220increase
(New Position)		 Filing